Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomideLAROCCA, Alessandra; CAVALLO, Federica; PATRIARCA, Francesca et al.Blood. 2012, Vol 119, Num 4, pp 933-939, issn 0006-4971, 7 p.Article

Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM verona 897) : An intensive and effective regimen for patients with aggressive, refractory or recurrent non-hodgkin lymphomas after anthracycline-containing regimensTODESCHINI, Giuseppe; TECCHIO, Cristina; PASINI, Felice et al.Cancer. 2005, Vol 104, Num 3, pp 555-560, issn 0008-543X, 6 p.Article

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized TrialPALUMBO, Antonio; CAVO, Michele; NOZZOLI, Chiara et al.Journal of clinical oncology. 2011, Vol 29, Num 8, pp 986-993, issn 0732-183X, 8 p.Article

The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosisTUCCI, Alessandra; MOTTA, Maddalena; UNGARI, Marco et al.Haematologica (Roma). 2005, Vol 90, Num 3, pp 348-352, issn 0390-6078, 5 p.Article

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myelomaCAVO, Michele; PANTANI, Lucia; NOZZOLI, Chiara et al.Blood. 2012, Vol 120, Num 1, pp 9-19, issn 0006-4971, 11 p.Article

Bortezomib As Induction Before Autologous Transplantation, Followed by Lenalidomide As Consolidation-Maintenance in Untreated Multiple Myeloma PatientsPALUMBO, Antonio; GAY, Francesca; GUGLIELMELLI, Tommasina et al.Journal of clinical oncology. 2010, Vol 28, Num 5, pp 800-807, issn 0732-183X, 8 p.Article

Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma : A report from the GIMEMA-Italian multiple myeloma networkPALUMBO, Antonio; FALCO, Patrizia; GAY, Francesca et al.Journal of clinical oncology. 2007, Vol 25, Num 28, pp 4459-4465, issn 0732-183X, 7 p.Article

Response-adjusted ISS (RaISS) is a simple and reliable prognostic scoring system for predicting progression-free survival in transplanted patients with multiple myelomaCORSO, Alessandro; GALLI, Monica; CAZZOLA, Mario et al.American journal of hematology. 2012, Vol 87, Num 2, pp 150-154, issn 0361-8609, 5 p.Article

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 studyCAVO, Michele; TACCHETTI, Paola; OFFIDANI, Massimo et al.Lancet (British edition). 2010, Vol 376, Num 9758, pp 2075-2085, issn 0140-6736, 11 p.Article

Feasibility and outcome of tandem stem cell autotransplants in multiple myelomaGALLI, Monica; NICOLUCCI, Antonio; VALENTINI, Miriam et al.Haematologica (Roma). 2005, Vol 90, Num 12, pp 1643-1649, issn 0390-6078, 7 p.Article